Literature DB >> 29571805

Imaging findings of hereditary renal tumors, a review of what the radiologist should know.

Marcin Czarniecki1, Rabindra Gautam2, Peter L Choyke3, Baris Turkbey3.   

Abstract

It is estimated that up to 8% of currently diagnosed renal cancers are part of a hereditary syndrome. The radiologist may be the first person to associate a renal tumor presenting during an imaging study to other manifestations of a hereditary syndrome. This diagnosis can have broad implications for the patient but also for other family members. This update reviews the current known associations and emerging mutations of hereditary renal cancers from a radiologist's perspective. Renal manifestations, as well as associated radiological findings and pitfalls are discussed. Additionally, screening and surveillance recommendations are also discussed to aid radiologists in the decision-making process for patient management. Published by Elsevier B.V.

Entities:  

Keywords:  Genetic predisposition to disease; Hereditary leiomyomatosis and renal cell cancer; Neoplasms; Renal cell carcinoma; Tuberous sclerosis; von Hippel-Lindau Disease

Mesh:

Year:  2018        PMID: 29571805     DOI: 10.1016/j.ejrad.2018.01.026

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  3 in total

Review 1.  Imaging for Screening and Surveillance of Patients with Hereditary Forms of Renal Cell Carcinoma.

Authors:  Yuval Freifeld; Lakshmi Ananthakrishnan; Vitaly Margulis
Journal:  Curr Urol Rep       Date:  2018-08-16       Impact factor: 3.092

2.  Clear Cell Renal Cell Carcinoma Growth Correlates with Baseline Diffusion-weighted MRI in Von Hippel-Lindau Disease.

Authors:  Faraz Farhadi; Moozhan Nikpanah; Anna K Paschall; Ahmad Shafiei; Ashkan Tadayoni; Mark W Ball; W Marston Linehan; Elizabeth C Jones; Ashkan A Malayeri
Journal:  Radiology       Date:  2020-04-07       Impact factor: 11.105

3.  Intrarenal urothelial cancers confused as infiltrative renal masses: Report of 22 cases and literature review.

Authors:  Xiaobo Ding; Xiaobo Ma; Yatao Jia; Hongfei Li; Yanbo Wang
Journal:  Oncol Lett       Date:  2018-06-01       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.